These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9493806)

  • 21. [Persistence of immune memory to hepatitis B vaccine among infants with normal or high antibody response to primary vaccination: a five-year following-up study].
    Zhang L; Yan B; Liu J; Lyu J; Feng Y; Xu A; Song L; Liang X; Li L; Cui F; Zhang G; Wang F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1372-6. PubMed ID: 26850392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to hepatitis B virus vaccine in 1-year-old preterm and term infants.
    Belson A; Reif S; Peled Y; Bujanover Y
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):252-5. PubMed ID: 8890074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
    Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses.
    Lai CL; Wong BC; Yeoh EK; Lim WL; Chang WK; Lin HJ
    Hepatology; 1993 Oct; 18(4):763-7. PubMed ID: 8406348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines: a comparison of two doses (10 microg and 5 microg).
    Chiu HH; Huang LM; Lee PI; Safary A; Lee CY
    Pediatr Infect Dis J; 1998 Mar; 17(3):206-11. PubMed ID: 9535247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
    Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.
    Wang C; Wang C; Jia ZF; Wu X; Wen SM; Kong F; Hu KQ; Li J; Jiang J; Niu JQ
    Medicine (Baltimore); 2016 Aug; 95(34):e4390. PubMed ID: 27559947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of recombinant hepatitis B vaccine among infants of mothers with active schistosomiasis.
    Bassily S; Kotkat A; Hyams KC; Youssef FG; El-Masry NA; Arthur R; Imam IZ; Brown FM
    Am J Trop Med Hyg; 1997 Aug; 57(2):197-9. PubMed ID: 9288816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.
    Dentinger CM; McMahon BJ; Butler JC; Dunaway CE; Zanis CL; Bulkow LR; Bruden DL; Nainan OV; Khristova ML; Hennessy TW; Parkinson AJ
    Pediatr Infect Dis J; 2005 Sep; 24(9):786-92. PubMed ID: 16148845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
    Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
    Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Schwarz TF; Behre U; Adelt T; Donner M; Suryakiran PV; Janssens W; Mesaros N; Panzer F
    Hum Vaccin Immunother; 2019; 15(1):235-241. PubMed ID: 30118633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study.
    Li AY; Liu Z; Song Y; Xiao Y; Jiang J; Li L; Zhai X; Liu J; Duan Z; Ding F; Liu J; Zhuang H; Zhu L; Jiang J; Zou H; Wang J; Li J
    Emerg Microbes Infect; 2020 Dec; 9(1):1881-1891. PubMed ID: 32779526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Leroux-Roels G; Crasta PD; Hardt K
    Hum Vaccin Immunother; 2012 Jul; 8(7):896-904. PubMed ID: 22777097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-HBs persistence after primary vaccination with three doses of 5 μg recombinant hepatitis B vaccine among normal and high-responder infants: 10-year of follow-up].
    Meng X; Lyu JJ; Feng Y; Dou X; Zhao X; Liang XF; Wang FZ; Xu AQ; Yan BY; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):794-799. PubMed ID: 35785861
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune response in infants after universal high-dose hepatitis B vaccination: A community-based study in Beijing, China.
    Xiao M; Qiu Q; Pang X; Liang X; Li L; Cui F; Wang F; Zhang G; Li H; Wang L; Zhang W
    Vaccine; 2015 Oct; 33(43):5878-5883. PubMed ID: 26117148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
    Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
    McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
    Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of preterm infants to hepatitis B vaccine.
    Lau YL; Tam AY; Ng KW; Tsoi NS; Lam B; Lam P; Yeung CY
    J Pediatr; 1992 Dec; 121(6):962-5. PubMed ID: 1447667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.